Data as of Mar 14
| +0.07 / +0.26%|
The 4 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 38.00, with a high estimate of 40.00 and a low estimate of 35.00. The median estimate represents a +38.58% increase from the last price of 27.42.
The current consensus among 4 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.